Dr. Regillo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4060 Butler Pike
Ste 200
Plymouth Meeting, PA 19462Phone+1 800-331-6634Fax+1 267-420-1360
Summary
- Dr. Carl D. Regillo is Professor of Ophthalmology at Thomas Jefferson University, Chief of the Retina Service of Wills Eye Hospital and Founder of the Wills Eye Clinical Retina Research Unit in Philadelphia. He received his medical degree from Harvard Medical School and performed his ophthalmology residency and vitreoretinal fellowship at Wills Eye Hospital. He has authored over 300 publications along with over 50 book chapters and 9 major books. He has been an investigator on numerous major clinical trials developing new medical and surgical treatments for retinal disorders such as macular degeneration and diabetic retinopathy. He is invited to lecture worldwide and serves on the scientific editorial board for several top ophthalmology peer-reviewed journals. As a recognized leader in the field, he is a recipient of the many local, national, and international awards including American Academy of Ophthalmology Achievement, Senior Achievement, Secretariat, and Lifetime Achievement Awards and the American Society of Retinal Specialists Honor, Senior Honor, Presidential, and Founders Awards. He was charter inductee of the Retina Hall of Fame and named in the Ophthalmologist Power List of the top 100 most influential ophthalmologists in the world. He was also listed among the top 150 ophthalmologists in the US by Newsweek.
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalFellowship, Surgical Retina and Vitreous, 1992 - 1994
- Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1989 - 1992
- Brigham and Women's HospitalInternship, Internal Medicine, 1988 - 1989
- Harvard Medical SchoolMD, 1984 - 1988
- Harvard Medical SchoolClass of 1988
- Northeastern UniversityBS, 1979 - 1984
Certifications & Licensure
- NJ State Medical License 1998 - 2025
- PA State Medical License 1990 - 2024
- CA State Medical License 1994 - 1998
- MA State Medical License 1984 - 1988
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- The Ophthalmologist Power List (Top 100 most influential people in the world of ophthalmology) The Ophthalmologist, 2018, 2020, 2022, 2024
- Top 150 Ophthalmologists in the US Newsweek, 2022
- America's Top Doctors Castle Connolly, 2007-2018
- Join now to see all
Clinical Trials
- Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration Start of enrollment: 2011 Jun 09
- Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy Start of enrollment: 2011 Jun 16
- Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion Start of enrollment: 2011 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 17 citationsBaseline Predictors of Vitreomacular Adhesion/Traction Resolution Following an Intravitreal Injection of Ocriplasmin.Timothy L Jackson, Carl D. Regillo, Aniz Girach, Pravin U. Dugel
Ophthalmic Surgery, Lasers & Imaging Retina. 2016-08-23 - 28 citationsEconomic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System.John S. Wittenborn, Traci E Clemons, Carl D. Regillo, Nadim Rayess, Danielle Liffmann Kruger
JAMA Ophthalmology. 2017-05-01 - 142 citationsTargeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration.Brian L. Yaspan, David F. Williams, Frank G. Holz, Carl D. Regillo, Zhengrong Li
Science Translational Medicine. 2017-06-21
Journal Articles
- Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM, Ophthalmology
- Pegaptanib for neovascular age-related macular degeneration.Gragoudas ES, Adamis AP, Cunningham ET, Jr, N Engl J Med
- Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage.Kupperman BD, Thomas EL, de Smet MD, Am J Ophthalmol
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Anecortave acetate administered sub-tenon’s retrobulbar with and without Visudyne PDT in patients with subfoveal age-related macular degeneration (AMD)-Clinical safety...D’Amico DJ, Duker J, Regillo C, Schneebaum C, Beasley C, Invest Ophthalmol Vis Sci
- Scleral buckling procedures decrease central retinal artery mean blood flow velocity.Regillo C, Sergott R, Brown G, Invest Ophthalmol Vis Sci
- Repair of AIDS retinitis-related retinal detachments with vitrectomy and silicone oil.Regillo C, Vander J, Fischer D, Belmont J, Kleiner R, Invest Ophthalmol Vis Sci
- Join now to see all
Lectures
- Anti-VEGF therapy for CRVO and BRVO.Newport Beach, CA
- Neovascular AMD treatment update 2012.Multiple locations
- Phamacologic vitreolysis and future management of symptomatic vitreomacular adhesion.A CME program by Retina Today and NRI. Aspen, CO
- Join now to see all
Press Mentions
- EyePoint Pharmaceuticals Doses First Patient in Phase 3 LUGANO Trial for Wet AMD Therapy DuravyuOctober 24th, 2024
- Adverum Biotechnologies Presents Positive End of Study Results from the OPTIC Trial in Wet AMD Including Two-Year Outcomes Following a Single Intravitreal Injection of Ixo-Vec (ADVM-022)November 5th, 2022
- Kodiak's Eylea Rival Hits 'Major Disappointment' with Failure in First of 6 Phase 3 StudiesFebruary 23rd, 2022
- Join now to see all
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: